Abstract
Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMBCL): Updated Analysis of the Keynote-170 Phase 2 Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have